US 12,144,789 B2
Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth
Nanshan Zhong, Guangzhou (CN); Longjiang Li, Chengdu (CN); Chia-Shun Shih, Taipei (TW); Lester J. Wu, Cape Coral, FL (US); and Mao-Yuan Lin, Taipei (TW)
Assigned to Gongwin Biopharm Co., Ltd., Taipei (TW)
Filed by Gongwin Biopharm Co., Ltd., Taipei (TW)
Filed on Jan. 19, 2022, as Appl. No. 17/579,013.
Application 17/579,013 is a continuation of application No. 15/245,170, filed on Aug. 23, 2016, abandoned.
Prior Publication US 2022/0133661 A1, May 5, 2022
Int. Cl. A61K 31/18 (2006.01); A61K 9/08 (2006.01); A61K 47/10 (2017.01)
CPC A61K 31/18 (2013.01) [A61K 9/08 (2013.01); A61K 47/10 (2013.01)] 14 Claims
 
1. A method for selectively treating a target cancer in a target body, comprising administering to the target body a pharmaceutical composition which comprises para-toluenesulfonamide having a concentration between 10 μmol/l and 40 μmol/l and a pharmaceutically acceptable carrier, wherein the para-toluenesulfonamide has a selectivity of the target cancer and normal cells, and wherein the selectivity of the target cancer and the normal cells is determined by a suppression ratio, which is percentage of cancer cell suppression divided by percentage of normal cell suppression, and wherein the suppression ratio is from 1.8 to 5.